Suppr超能文献

用 SARS-CoV-2 刺突蛋白假型化的人类免疫缺陷病毒通过多种进入机制感染广泛的人类细胞系。

Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms.

机构信息

Public Health Research Institute, Rutgers, the State University of New Jersey, Newark, NJ 07103, USA.

Laboratory Medicine, Rutgers, Department of Pathology, Immunology, the State University of New Jersey, Newark, NJ 07103, USA.

出版信息

Viruses. 2021 May 21;13(6):953. doi: 10.3390/v13060953.

Abstract

Severe acute respiratory syndrome-related coronavirus (SARS-CoV-2), the causative agent of coronavirus disease 19 (COVID-19), enters cells through attachment to the human angiotensin converting enzyme 2 (hACE2) via the receptor-binding domain (RBD) in the surface/spike (S) protein. Several pseudotyped viruses expressing SARS-CoV-2 S proteins are available, but many of these can only infect hACE2-overexpressing cell lines. Here, we report the use of a simple, two-plasmid, pseudotyped virus system comprising a SARS-CoV-2 spike-expressing plasmid and an HIV vector with or without to investigate the SARS-CoV-2 entry event in various cell lines. When an HIV vector without was used, pseudotyped SARS-CoV-2 viruses produced in the presence of fetal bovine serum (FBS) were able to infect only engineered hACE2-overexpressing cell lines, whereas viruses produced under serum-free conditions were able to infect a broader range of cells, including cells without hACE2 overexpression. When an HIV vector containing was used, pseudotyped viruses were able to infect a broad spectrum of cell types regardless of whether viruses were produced in the presence or absence of FBS. Infection sensitivities of various cell types did not correlate with mRNA abundance of hACE2, TMPRSS2, or TMPRSS4. Pseudotyped SARS-CoV-2 viruses and replication-competent SARS-CoV-2 virus were equally sensitive to neutralization by an anti-spike RBD antibody in cells with high abundance of hACE2. However, the anti-spike RBD antibody did not block pseudotyped viral entry into cell lines with low abundance of hACE2. We further found that CD147 was involved in viral entry in A549 cells with low abundance of hACE2. Thus, our assay is useful for drug and antibody screening as well as for investigating cellular receptors, including hACE2, CD147, and tyrosine-protein kinase receptor UFO (AXL), for the SARS-CoV-2 entry event in various cell lines.

摘要

严重急性呼吸综合征相关冠状病毒(SARS-CoV-2)是导致 2019 冠状病毒病(COVID-19)的病原体,它通过表面/刺突(S)蛋白中的受体结合结构域(RBD)与人类血管紧张素转化酶 2(hACE2)结合进入细胞。目前有多种表达 SARS-CoV-2 S 蛋白的假型病毒,但其中许多只能感染 hACE2 过表达的细胞系。在这里,我们报告了一种简单的、由两质粒组成的假型病毒系统的使用情况,该系统由表达 SARS-CoV-2 刺突蛋白的质粒和带有或不带 的 HIV 载体组成,用于研究各种细胞系中的 SARS-CoV-2 进入事件。当使用不含 的 HIV 载体时,在胎牛血清(FBS)存在的情况下产生的假型 SARS-CoV-2 病毒只能感染经过工程改造的 hACE2 过表达细胞系,而在无血清条件下产生的病毒能够感染更广泛的细胞类型,包括没有 hACE2 过表达的细胞。当使用含有 的 HIV 载体时,假型病毒能够感染广泛的细胞类型,无论病毒是在 FBS 存在还是不存在的情况下产生。各种细胞类型的感染敏感性与 hACE2、TMPRSS2 或 TMPRSS4 的 mRNA 丰度无关。假型 SARS-CoV-2 病毒和复制型 SARS-CoV-2 病毒对高 hACE2 丰度细胞中抗刺突 RBD 抗体的中和作用同样敏感。然而,抗刺突 RBD 抗体并不能阻止低 hACE2 丰度细胞系中的假型病毒进入。我们进一步发现,CD147 参与了低 hACE2 丰度的 A549 细胞中的病毒进入。因此,我们的测定方法可用于药物和抗体筛选,以及研究包括 hACE2、CD147 和酪氨酸蛋白激酶受体 UFO(AXL)在内的细胞受体,以研究各种细胞系中的 SARS-CoV-2 进入事件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db6c/8224355/4084d664f3a5/viruses-13-00953-g004.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验